Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis.

Uzzo, Martina; Regola, Francesca; Trezzi, Barbara; Toniati, Paola; Franceschini, Franco; Sinico, Renato Alberto

Uzzo, Martina; Regola, Francesca; Trezzi, Barbara; Toniati, Paola; Franceschini, Franco; Sinico, Renato Alberto.

Afiliação

Uzzo M; Department of Clinical and Experimental Sciences, University of Milano-Bicocca, Monza, Italy.
Regola F; Nephrology and Dialysis Unit, Ospedale San Gerardo di Monza, Monza, Italy.
Trezzi B; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Toniati P; Rheumatology and Clinical Immunology Unit, ASST-Spedali Civili of Brescia, Brescia, Italy.
Franceschini F; Department of Clinical and Experimental Sciences, University of Milano-Bicocca, Monza, Italy.
Sinico RA; Nephrology and Dialysis Unit, Ospedale San Gerardo di Monza, Monza, Italy.

Front Med (Lausanne) ; 8: 754434, 2021.

Article em En | MEDLINE | ID: mdl-34796188

Palavras-chave

Eosinophilic Granulomatosis with Polyangiitis; biologics; heart involvement; mepolizumab; novel therapies; omalizumab; rituximab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália